共 90 条
[1]
Abolghasemi H(2007)Thalassemia in Iran—epidemiology, prevention, and management J Pediatr Hematol Oncol 29 233-238
[2]
Keramati MR(2013)Screening of hemoglobin disorders in referral cases to the hospital’s laboratory in northeast Iran Int J Hematol Oncol 23 138-142
[3]
Sadeghian MH(2014)Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major Front Pharmacol 5 217-977
[4]
Ayatillahi H(2000)Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major Br J Haematol 110 971-1786
[5]
Younes Y(2012)Measurement of liver iron overload: noninvasive calibration of MRI-R2* by magnetic iron detector susceptometer Magn Reson Med 67 1782-260
[6]
Baksi AJ(2012)Correlation of cardiac MRI T2* with echocardiography in thalassemia major Eur Rev Med Pharmacol Sci 16 254-111
[7]
Pennell DJ(2014)Effective iron chelation practice for patients with beta-thalassemia major Clin J Oncol Nurs 18 102-783
[8]
Telfer PT(2008)Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias Am J Hematol 83 781-1374
[9]
Prestcott E(2013)International survey of T2* cardiovascular magnetic resonance in beta-thalassemia major Haematologica 98 1368-1219
[10]
Holden S(2013)CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort Clin Biochem 46 1197-86